Oligonucleotides (oligos) are short strands of synthetic DNA or RNA crucial in developing advanced therapies, including those for genetic disorders and cancer. AKBA stood out for creating a novel ...

Asahi Kasei Bioprocess America is part of the Asahi Kasei Life Science operating segment, encompassing the organization’s purification, fluid management, biosafety, and biologics development and ...

Asahi Kasei Bioprocess America is expanding to increase its Glenview facility to 43,000 square feet – Targeting completion in mid-2023. R&D and production capacity will be doubled for Fluid Management ...

Officials at GE Healthcare say the company has completed the acquisition of Puridify, a bioprocessing UK startup that is developing a nanofiber-based platform purification technology for ...

In the downstream portion of any bioprocess, one must pick through the dross before one can seize the gold—the biotherapeutic that the bioprocess was always meant to generate. Unfortunately, the dross ...

Avitide Inc.Lebanon, has announced it has finished development of an affinity bioprocess resin for the purification of recombinant Covid-19 vaccines. The AVIPure-COV2S resin is a capture resin for the ...

To date, CAV-2 vectors have been produced in a cell line generated from dog kidney (DK). 2 However, these cells are not regulated for biopharmaceutical production, which precludes the potential ...

GE Healthcare has announced the opening of a biotechnology manufacturing centre at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in Stevenage, UK. GE Healthcare has announced the ...